PDPR — Marathon Share Price
Last trade - 00:00- $0.01m
- $2.81m
- $1.75m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -32.77% | ||
Financial Summary
| Year End 31st Dec | Unit | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.72 | 0.86 | 0.49 | 1.4 | 1.75 | n/a | n/a | 25.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Marathon Group Corporation is engaged in the business of software development and sale of legal cannabis products. The Company has developed a point-of-sale platform for retail stores. The software manages the front end and back end of a retail store. The Company markets cannabidiol (CBD) products, including 1,500 mg Nano-Pure Ultra CBD Drops, Tasty Drops 4 Pets, and Muscle & Joint Salve. 1,500 mg Nano-Pure Ultra CBD Drops is made with hemp extract, organic coconut oil and medium-chain-triglycerides to promote absorption and relief for a variety of health conditions. Tasty Drops 4 Pets is a blend of hemp oil for use as a food supplement for dogs. Muscle & Joint Salve is a topical pain-relief product. These products are marketed under the tradename MarathonRx and sold on the Website, www.marathonrx.com. The Company conducts its CBD products business through its wholly owned subsidiary, MarathonRx Inc.
Directors
- Last Annual
- December 31st, 2012
- Last Interim
- March 31st, 2013
- Incorporated
- January 29th, 1954
- Public Since
- July 12th, 2001
- No. of Employees
- 6
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 6,934,531,666
- Address
- 12926 Willow Chase Dr, HOUSTON, 77070
- Web
- Phone
- +1 2818971108
- Auditors
- Malone Bailey, LLP
Similar to PDPR
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advantego
Pink Sheets on Nasdaq
FAQ
As of Today at 21:53 UTC, shares in Marathon are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Marathon last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Marathon share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out moreMarathon does not currently pay a dividend.
Marathon does not currently pay a dividend.
Marathon does not currently pay a dividend.
To buy shares in Marathon you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Marathon had a market capitalisation of $0.01m.
Here are the trading details for Marathon:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PDPR
Based on an overall assessment of its quality, value and momentum Marathon is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Marathon. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.00, shares in Marathon were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Marathon PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Marathon's management team is headed by:
- Linda Putback-Bean - CEO
- Kenneth Bean - CFO
- Dan Morgan - VPR
- Jean Gonzalez - OTH